SS Innovations International, Inc. (Nasdaq: SSII), a developer of surgical robotic technologies, announced today that its SSi Mantra surgical robotic system has been used in more than 10,500 cumulative surgeries as of April 30, 2026. The milestone includes over 500 cardiac procedures, 170 telesurgeries, and 125 pediatric surgeries, with more than 2,100 physicians trained on the system. The SSi Mantra has been utilized to perform over 170 different types of procedures across multiple specialties.
Since its commercial launch in August 2022, the SSi Mantra has established a presence in the Indian market and expanded its global installed base to over 200 systems across eleven countries. The system's advanced technology, ease of training, user-friendliness, and cost advantages have driven its rapid adoption. Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, stated, 'Reaching 10,500 cumulative surgeries in such a short time span reflects the SSi Mantra’s advanced technology, differentiated features, ease of training, user-friendliness, and clear cost advantages.' He emphasized the company's mission to democratize access to world-class surgical robotic care.
The SSi Mantra is a modular, multi-arm system with features including an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and optional tele-surgeon console for enhanced portability and telesurgery capability. The system supports over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries. It has been clinically validated in India in more than 100 types of surgical procedures.
The implications of this announcement are significant for the global healthcare industry. The SSi Mantra's cost advantages and user-friendly design may enable more hospitals, particularly in emerging markets, to offer robotic surgery, potentially expanding patient access to minimally invasive procedures. The milestone of over 10,500 surgeries demonstrates that the system is gaining traction as a viable alternative to established robotic surgery systems, which could increase competition and drive down costs industry-wide. Additionally, the inclusion of 170 telesurgeries highlights the potential for remote surgical care, which could improve access in underserved areas. As SS Innovations expands its global presence, its technology could play a role in transforming surgical care worldwide.
